Literature DB >> 29793936

Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Miruna Popa1, Sibgha Tahir1, Julia Elrod1, Su Hwan Kim1, Florian Leuschner2,3, Thorsten Kessler4, Peter Bugert5, Ulrich Pohl6,7, Andreas H Wagner8, Markus Hecker1,3.   

Abstract

Monocyte extravasation into the vessel wall is a key step in atherogenesis. It is still elusive how monocytes transmigrate through the endothelial cell (EC) monolayer at atherosclerosis predilection sites. Platelets tethered to ultra-large von Willebrand factor (ULVWF) multimers deposited on the luminal EC surface following CD40 ligand (CD154) stimulation may facilitate monocyte diapedesis. Human ECs grown in a parallel plate flow chamber for live-cell imaging or Transwell permeable supports for transmigration assay were exposed to fluid or orbital shear stress and CD154. Human isolated platelets and/or monocytes were superfused over or added on top of the EC monolayer. Plasma levels and activity of the ULVWF multimer-cleaving protease ADAMTS13 were compared between coronary artery disease (CAD) patients and controls and were verified by the bioassay. Two-photon intravital microscopy was performed to monitor CD154-dependent leukocyte recruitment in the cremaster microcirculation of ADAMTS13-deficient versus wild-type mice. CD154-induced ULVWF multimer-platelet string formation on the EC surface trapped monocytes and facilitated transmigration through the EC monolayer despite high shear stress. Two-photon intravital microscopy revealed CD154-induced ULVWF multimer-platelet string formation preferentially in venules, due to strong EC expression of CD40, causing prominent downstream leukocyte extravasation. Plasma ADAMTS13 abundance and activity were significantly reduced in CAD patients and strongly facilitated both ULVWF multimer-platelet string formation and monocyte trapping in vitro. Moderate ADAMTS13 deficiency in CAD patients augments CD154-mediated deposition of platelet-decorated ULVWF multimers on the luminal EC surface, reinforcing the trapping of circulating monocytes at atherosclerosis predilection sites and promoting their diapedesis.

Entities:  

Keywords:  ADAMTS13; CD40; coronary artery disease; endothelial cells; von Willebrand factor

Mesh:

Substances:

Year:  2018        PMID: 29793936      PMCID: PMC6004483          DOI: 10.1073/pnas.1801366115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  72 in total

1.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

2.  Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction.

Authors:  K Kaikita; K Soejima; M Matsukawa; T Nakagaki; H Ogawa
Journal:  J Thromb Haemost       Date:  2006-08-08       Impact factor: 5.824

Review 3.  Monocyte heterogeneity in human cardiovascular disease.

Authors:  Adam M Zawada; Kyrill S Rogacev; Stephan H Schirmer; Martina Sester; Michael Böhm; Danilo Fliser; Gunnar H Heine
Journal:  Immunobiology       Date:  2012-07-25       Impact factor: 3.144

Review 4.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

5.  Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling.

Authors:  Michael P Kuligowski; A Richard Kitching; Michael J Hickey
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

Review 6.  Unwinding the von Willebrand factor strings puzzle.

Authors:  Karen De Ceunynck; Simon F De Meyer; Karen Vanhoorelbeke
Journal:  Blood       Date:  2012-10-23       Impact factor: 22.113

Review 7.  Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases.

Authors:  Janine M van Gils; Jaap Jan Zwaginga; Peter L Hordijk
Journal:  J Leukoc Biol       Date:  2008-10-23       Impact factor: 4.962

8.  Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Authors:  Koichi Kokame; Masanori Matsumoto; Kenji Soejima; Hideo Yagi; Hiromichi Ishizashi; Masahisa Funato; Hiroshi Tamai; Mutsuko Konno; Kei Kamide; Yuhei Kawano; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

Review 9.  Biochemistry and genetics of von Willebrand factor.

Authors:  J E Sadler
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

10.  The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNFα -induced inflammation in vivo.

Authors:  Elisabeth Koch; Joachim Pircher; Thomas Czermak; Erik Gaitzsch; Stefan Alig; Hanna Mannell; Markus Niemeyer; Florian Krötz; Markus Wörnle
Journal:  Mediators Inflamm       Date:  2013-05-09       Impact factor: 4.711

View more
  12 in total

1.  The mechanism by which enoxaparin sodium-high-viscosity bone cement reduces thrombosis by regulating CD40 expression in endothelial cells.

Authors:  Linchao Sang; Kangning Hao; Luobin Ding; Xiaoyu Shen; Hui Sun; Dehao Fu; Xiangbei Qi
Journal:  BMC Musculoskelet Disord       Date:  2022-05-30       Impact factor: 2.562

2.  Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.

Authors:  Yllka Latifi; Federico Moccetti; Melinda Wu; Aris Xie; William Packwood; Yue Qi; Koya Ozawa; Weihui Shentu; Eran Brown; Toshiaki Shirai; Owen J McCarty; Zaverio Ruggeri; Javid Moslehi; Junmei Chen; Brian J Druker; Jose A López; Jonathan R Lindner
Journal:  Blood       Date:  2019-01-28       Impact factor: 25.476

Review 3.  Whole Blood Based Multiparameter Assessment of Thrombus Formation in Standard Microfluidic Devices to Proxy In Vivo Haemostasis and Thrombosis.

Authors:  Isabella Provenzale; Sanne L N Brouns; Paola E J van der Meijden; Frauke Swieringa; Johan W M Heemskerk
Journal:  Micromachines (Basel)       Date:  2019-11-16       Impact factor: 2.891

4.  The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice.

Authors:  Frederik Denorme; Kimberly Martinod; Aline Vandenbulcke; Cécile V Denis; Peter J Lenting; Hans Deckmyn; Karen Vanhoorelbeke; Simon F De Meyer
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

Review 5.  Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?

Authors:  Mehran Ghasemzadeh; Javad Ahmadi; Ehteramolsadat Hosseini
Journal:  Thromb Res       Date:  2022-03-31       Impact factor: 10.407

6.  Interaction of von Willebrand factor with blood cells in flow models: a systematic review.

Authors:  Ryanne A Arisz; Judith J de Vries; Saskia E M Schols; Jeroen C J Eikenboom; Moniek P M de Maat
Journal:  Blood Adv       Date:  2022-07-12

7.  [Correlation of serum ADAMTS13 and TSP1 levels with myocardial injury and prognosis in patients with acute coronary syndrome].

Authors:  Z Yao; B Bao; S Qian; Z Li; Q Lu; S Min; M Li; H Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20

Review 8.  CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease-The Pros and Cons for Cardioprotection.

Authors:  Steffen Daub; Esther Lutgens; Thomas Münzel; Andreas Daiber
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

9.  Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.

Authors:  Eugenio D Hottz; Isaclaudia G Azevedo-Quintanilha; Lohanna Palhinha; Lívia Teixeira; Ester A Barreto; Camila R R Pão; Cassia Righy; Sérgio Franco; Thiago M L Souza; Pedro Kurtz; Fernando A Bozza; Patrícia T Bozza
Journal:  Blood       Date:  2020-09-10       Impact factor: 22.113

Review 10.  The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

Authors:  Laura A Bosmans; Lena Bosch; Pascal J H Kusters; Esther Lutgens; Tom T P Seijkens
Journal:  J Cardiovasc Transl Res       Date:  2020-03-28       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.